Table 2 Subset of data extraction table –five of 112 studies shown (full table in Additional file 3)

[31]

2008

Nigeria

1996–2004

RB

IVM

Community

4800 surveyed

49.96 % overall participation

n/a

No

Presented as ‘coverage’ yet discussed as ‘participation’

[32]

2007

Sri Lanka

2003

LF

DEC + ALB

Community

4358 surveyed

71.4 %

Taking other medication (3.1 %), felt they did not need them (3.2 %), had forgotten to consume them (1.1 %), worried about adverse effects (0.8 %)

No

Compliance: those who consumed drug over eligible population

[34]

2013

India

2008

LF

DEC

Community

571 eligible

42.3 %

No motivation (24.7 %), drugs not supplied (22.5 %), absence at home (13.5 %), no faith (10.1 %), fear of side effects (10.1 %) and others: Forgotten, lack of prior IEC etc. (7.8 %), illness (7.3 %), wrong information (3.9 %)

No

Compliance: consumption of drug among those who received drug; defaulter: did not consume drug, or partially consumed drug, or those who were not supplied the drug by the drug distributors

[30]

1991

Liberia

1987–1989

RB

IVM

Community

1987: 13,704; 1988: 13,977; 1989: 14,110

1987: 96.8 % (56.2 % of total pop); 1988: 96.6 % (57.7 % of total pop); 1989: 98.4 % (70.9 % of total pop)

n/a

No

Referred to as ‘those who accepted treatment’ using eligible population as denominator

[53]

2006

India

2001–2003

LF

DEC/DEC + ALB

Community

unspecified

MDA rounds 1–3 consumption rate: 34.9 %, 39.8 %, 41.7 % (of total population); 35.5 %, 40.3 %, 42.4 % (of eligible); 46.9 %, 51.7 %, 50 % (of drug recipients)

MDA rounds 1–3: not necessary (31.8 %, 52.9 %, 42.9 %), fear of side reactions (24.6 %, 20.7 %, 30.1 %), treatment for other diseases (8.9 %, 4.4 %, 11.3 %), no opinion/no response (19.2 %, 2.5 %, 6.5 %), partial consumption (6.6 %, 4.4 %, 5.6 %), others (8.9 %, 15.1 %, 3.6 %)

No

Referred to as consumption rate and presented in terms of total population, of eligible population, and of those who received drug